What is the recommended approach to screening for substance use disorders in schizophrenia?

• A. Validated tools to screen for alcohol, cannabis, stimulants, and other substances
• B. Self-report only without tools
• C. Urine screen only
• D. No assessment

Answer: (B)

Screening for substance use in schizophrenia should begin with a direct, patient-centered self-report interview. This approach matters because the patient’s own words reveal not only what substances are used, but also how use relates to mood, cognition, hallucinations, and daily functioning. A candid conversation builds trust, increases the likelihood that hidden use will be disclosed, and helps capture patterns such as frequency, quantity, triggers, and consequences that tests alone might miss.

Self-report provides essential context—why someone uses, how use varies across symptoms or stressors, and how it affects treatment adherence and safety. While objective tools and urine or other biological tests have value and are often used as follow-up or confirmatory steps, they work best when anchored in a patient’s narrative and rapport. Relying on no assessment would miss critical information about risks and needs, and using only a laboratory test or only standardized tools could overlook the subjective experience and functional impact of substance use.

In practice, you start with a compassionate, structured self-report discussion, and then supplement with validated screens or objective measures as appropriate to confirm findings and guide intervention. This balance maximizes detection while respecting the patient’s perspective and supports a more integrated treatment plan.